[8-K] Exagen Inc. Reports Material Event

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Analyzing...

07/17/2025 - 04:33 PM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Exagen Inc.

NASDAQ:XGN

XGN Rankings

#7269 Ranked by Market Cap

N/A Ranked by Dividends

XGN Latest News

Jul 17, 2025

Exagen Inc. Appoints Chas McKhann to Board of Directors

Jul 15, 2025

Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025

Jun 23, 2025

Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics

May 9, 2025

Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares

May 8, 2025

Exagen Inc. Prices Public Offering of Common Stock

XGN Latest SEC Filings

Jul 3, 2025

[EFFECT] Exagen Inc. SEC Filing

Jun 20, 2025

[S-3] Exagen Inc. Shelf Registration Statement

XGN Stock Data

Market Cap 149.31M

Float 13.98M

Insiders Ownership 27.64%

Institutions Ownership 54.26%

Short Percent 0.13%

Industry Diagnostics & Research

Sector Services-medical Laboratories

Website Link

Country United States

City VISTA